Trade Mark Journal No.2026/021 22 May 2026

UK00004381574 1 May 2026 (42,44)

PAIGE PREDICT

International priority date claimed: 9 February 2026 (United States of America) (99642517)

Class 42: Scientific and technological services, namely, scientific research, analysis, and testing in the fields of pathology, histology, and medical images; Providing temporary use of online non-downloadable software for digital and diagnostic assays for detecting and predicting biomarkers based on pathology slides; Providing temporary use of online non-downloadable software for digital and diagnostic assays for detecting and predicting biomarkers and mutations across multiple cancer types using pathology slides; providing temporary use of non-downloadable computer software for analyzing health information in support of making medical decisions in the medical field; providing medical and scientific research information in the fields of oncology and genetic research; providing temporary use of non-downloadable computer software for analyzing and predicting nucleic acid yield.
Class 44: Medical testing services using digital and diagnostic assays for detecting and predicting biomarkers based on pathology slides; medical testing services using digital and diagnostic assays for detecting and predicting biomarkers and mutations across multiple cancer types using pathology slides; medical services; providing medical information in the field of oncology; medical services in the field of oncology diagnostics and testing; providing medical diagnostic testing that analyzes patient samples and predicts nucleic acid yield.

Tempus AI, Inc.

Representative: Brabners LLP